| 0 |
PANTOTHENIC ACID DEFICIENCY |
1 |
0.2500 |
| 1 |
INFUSION SITE NERVE DAMAGE |
1 |
0.0312 |
| 2 |
INCISION SITE PRURITUS |
1 |
0.0119 |
| 3 |
EUSTACHIAN TUBE OBSTRUCTION |
1 |
0.0061 |
| 4 |
VITAMIN C DEFICIENCY |
1 |
0.0051 |
| 5 |
VACCINATION SITE ERYTHEMA |
1 |
0.0046 |
| 6 |
CHEST WALL HAEMATOMA |
1 |
0.0039 |
| 7 |
INTERVERTEBRAL DISC DISPLACEMENT |
2 |
0.0038 |
| 8 |
BINOCULAR EYE MOVEMENT DISORDER |
1 |
0.0035 |
| 9 |
OESOPHAGEAL MOTILITY DISORDER |
1 |
0.0028 |
| 10 |
AORTIC OCCLUSION |
1 |
0.0024 |
| 11 |
VITAL CAPACITY DECREASED |
1 |
0.0022 |
| 12 |
BLOOD CHOLESTEROL |
1 |
0.0021 |
| 13 |
APPLICATION SITE INFECTION |
1 |
0.0020 |
| 14 |
PSEUDOLYMPHOMA |
1 |
0.0018 |
| 15 |
OCCIPITAL NEURALGIA |
1 |
0.0018 |
| 16 |
VACCINATION SITE PAIN |
1 |
0.0017 |
| 17 |
LACRIMAL DISORDER |
1 |
0.0017 |
| 18 |
HYPOAESTHESIA EYE |
1 |
0.0017 |
| 19 |
PAROTID GLAND ENLARGEMENT |
1 |
0.0015 |
| 20 |
POSITRON EMISSION TOMOGRAM ABNORMAL |
1 |
0.0014 |
| 21 |
BUNION |
1 |
0.0014 |
| 22 |
PANCREATITIS RELAPSING |
1 |
0.0012 |
| 23 |
PULMONARY NOCARDIOSIS |
1 |
0.0012 |
| 24 |
OESOPHAGEAL OBSTRUCTION |
1 |
0.0012 |
| 25 |
FACIAL ASYMMETRY |
1 |
0.0010 |
| 26 |
INFUSION SITE NODULE |
1 |
0.0010 |
| 27 |
INFUSION SITE DISCOMFORT |
1 |
0.0010 |
| 28 |
BURNS THIRD DEGREE |
1 |
0.0009 |
| 29 |
BONE DEMINERALISATION |
1 |
0.0009 |
| 30 |
APPLICATION SITE PAPULES |
1 |
0.0009 |
| 31 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
1 |
0.0009 |
| 32 |
POST PROCEDURAL SWELLING |
1 |
0.0009 |
| 33 |
BREATH ODOUR |
2 |
0.0008 |
| 34 |
INFUSION SITE WARMTH |
1 |
0.0008 |
| 35 |
APPLICATION SITE SCAR |
1 |
0.0008 |
| 36 |
INFUSION SITE IRRITATION |
1 |
0.0008 |
| 37 |
INFUSION SITE RASH |
1 |
0.0007 |
| 38 |
COCCYDYNIA |
1 |
0.0007 |
| 39 |
INFUSION SITE INDURATION |
1 |
0.0007 |
| 40 |
ENTHESOPATHY |
1 |
0.0006 |
| 41 |
GASTROINTESTINAL STOMA COMPLICATION |
1 |
0.0006 |
| 42 |
INFUSION SITE DISCHARGE |
1 |
0.0006 |
| 43 |
BURNS SECOND DEGREE |
1 |
0.0006 |
| 44 |
SACROILIITIS |
1 |
0.0005 |
| 45 |
TORTICOLLIS |
1 |
0.0005 |
| 46 |
APPLICATION SITE SCAB |
1 |
0.0005 |
| 47 |
SINUS PAIN |
1 |
0.0004 |
| 48 |
INGROWING NAIL |
1 |
0.0004 |
| 49 |
VOLVULUS |
1 |
0.0004 |
| 50 |
BRONCHITIS CHRONIC |
1 |
0.0004 |
| 51 |
APPLICATION SITE BURN |
2 |
0.0004 |
| 52 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
2 |
0.0004 |
| 53 |
ENDODONTIC PROCEDURE |
1 |
0.0004 |
| 54 |
THERAPEUTIC RESPONSE DELAYED |
1 |
0.0004 |
| 55 |
INFUSION SITE ERYTHEMA |
3 |
0.0004 |
| 56 |
RESPIRATORY SYMPTOM |
1 |
0.0004 |
| 57 |
PHARYNGEAL DISORDER |
1 |
0.0003 |
| 58 |
LUMBAR SPINAL STENOSIS |
1 |
0.0003 |
| 59 |
METABOLIC ENCEPHALOPATHY |
1 |
0.0003 |
| 60 |
DRUG EFFECT INCREASED |
1 |
0.0003 |
| 61 |
ROTATOR CUFF SYNDROME |
4 |
0.0003 |
| 62 |
PRODUCT ODOUR ABNORMAL |
3 |
0.0003 |
| 63 |
CAROTID ARTERY STENOSIS |
1 |
0.0003 |
| 64 |
JAUNDICE CHOLESTATIC |
1 |
0.0003 |
| 65 |
LUNG TRANSPLANT |
1 |
0.0003 |
| 66 |
SPONDYLITIS |
1 |
0.0003 |
| 67 |
MICTURITION URGENCY |
3 |
0.0003 |
| 68 |
SUSPECTED COUNTERFEIT PRODUCT |
1 |
0.0003 |
| 69 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
2 |
0.0002 |
| 70 |
INTERVERTEBRAL DISC DISORDER |
1 |
0.0002 |
| 71 |
INFUSION SITE PAIN |
3 |
0.0002 |
| 72 |
VULVOVAGINAL DISCOMFORT |
1 |
0.0002 |
| 73 |
VASCULAR DEVICE INFECTION |
1 |
0.0002 |
| 74 |
RENAL FUNCTION TEST ABNORMAL |
1 |
0.0002 |
| 75 |
SENSITIVITY TO WEATHER CHANGE |
1 |
0.0002 |
| 76 |
ANORECTAL DISCOMFORT |
1 |
0.0002 |
| 77 |
FOOD POISONING |
1 |
0.0002 |
| 78 |
FOOT DEFORMITY |
2 |
0.0002 |
| 79 |
BLOOD CALCIUM DECREASED |
2 |
0.0002 |
| 80 |
DERMATITIS CONTACT |
2 |
0.0002 |
| 81 |
INTERNAL HAEMORRHAGE |
2 |
0.0002 |
| 82 |
SKIN WARM |
1 |
0.0002 |
| 83 |
DECREASED INTEREST |
1 |
0.0002 |
| 84 |
ADRENAL INSUFFICIENCY |
2 |
0.0002 |
| 85 |
SCOLIOSIS |
1 |
0.0002 |
| 86 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 87 |
ENTERITIS |
1 |
0.0002 |
| 88 |
ANGINA UNSTABLE |
1 |
0.0002 |
| 89 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 90 |
APPETITE DISORDER |
1 |
0.0002 |
| 91 |
COLITIS ISCHAEMIC |
1 |
0.0001 |
| 92 |
PERIPHERAL COLDNESS |
2 |
0.0001 |
| 93 |
ONYCHOCLASIS |
1 |
0.0001 |
| 94 |
MASS |
2 |
0.0001 |
| 95 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 96 |
INSURANCE ISSUE |
2 |
0.0001 |
| 97 |
DISSOCIATION |
1 |
0.0001 |
| 98 |
TENDONITIS |
2 |
0.0001 |
| 99 |
APNOEA |
1 |
0.0001 |
| 100 |
THERAPY PARTIAL RESPONDER |
2 |
0.0001 |
| 101 |
ATRIAL FLUTTER |
1 |
0.0001 |
| 102 |
RHINITIS |
1 |
0.0001 |
| 103 |
MYASTHENIA GRAVIS |
1 |
0.0001 |
| 104 |
FRUSTRATION TOLERANCE DECREASED |
1 |
0.0001 |
| 105 |
ABNORMAL FAECES |
1 |
0.0001 |
| 106 |
PSEUDOMONAS INFECTION |
1 |
0.0001 |
| 107 |
URINE OUTPUT DECREASED |
1 |
0.0001 |
| 108 |
GASTRITIS |
3 |
0.0001 |
| 109 |
SPINAL OSTEOARTHRITIS |
1 |
0.0001 |
| 110 |
MYOSITIS |
1 |
0.0001 |
| 111 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 112 |
EXOSTOSIS |
1 |
0.0001 |
| 113 |
SKIN LESION |
3 |
0.0001 |
| 114 |
INCREASED TENDENCY TO BRUISE |
1 |
0.0001 |
| 115 |
NERVE COMPRESSION |
1 |
0.0001 |
| 116 |
INTERVERTEBRAL DISC DEGENERATION |
1 |
0.0001 |
| 117 |
BACTERIAL INFECTION |
2 |
0.0001 |
| 118 |
HEPATIC ENCEPHALOPATHY |
1 |
0.0001 |
| 119 |
FLANK PAIN |
1 |
0.0001 |
| 120 |
SEROTONIN SYNDROME |
2 |
0.0001 |
| 121 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 122 |
KNEE OPERATION |
1 |
0.0001 |
| 123 |
INABILITY TO AFFORD MEDICATION |
1 |
0.0001 |
| 124 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
1 |
0.0001 |
| 125 |
TASTE DISORDER |
2 |
0.0001 |
| 126 |
TOOTH ABSCESS |
1 |
0.0001 |
| 127 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
1 |
0.0001 |
| 128 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 129 |
TRANSFUSION |
1 |
0.0001 |
| 130 |
FOLLICULITIS |
1 |
0.0001 |
| 131 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
0.0001 |
| 132 |
SCRATCH |
1 |
0.0001 |
| 133 |
HYPOTHYROIDISM |
3 |
0.0001 |
| 134 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 135 |
INTERVERTEBRAL DISC PROTRUSION |
2 |
0.0001 |
| 136 |
DENTAL CARIES |
1 |
0.0001 |
| 137 |
NERVE INJURY |
1 |
0.0001 |
| 138 |
MALNUTRITION |
1 |
0.0001 |
| 139 |
EYE PRURITUS |
3 |
0.0001 |
| 140 |
SKIN INFECTION |
1 |
0.0001 |
| 141 |
NEOPLASM |
1 |
0.0001 |
| 142 |
ATAXIA |
1 |
0.0001 |
| 143 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 144 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 145 |
ANKYLOSING SPONDYLITIS |
1 |
0.0001 |
| 146 |
TOOTH INFECTION |
1 |
0.0001 |
| 147 |
UVEITIS |
1 |
0.0001 |
| 148 |
MOOD ALTERED |
2 |
0.0001 |
| 149 |
APPLICATION SITE RASH |
1 |
0.0001 |
| 150 |
HYPOMAGNESAEMIA |
1 |
0.0001 |
| 151 |
NECK PAIN |
4 |
0.0001 |
| 152 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 153 |
PRODUCT DOSE OMISSION IN ERROR |
2 |
0.0001 |
| 154 |
FLATULENCE |
4 |
0.0001 |
| 155 |
PARALYSIS |
1 |
0.0001 |
| 156 |
HYPOKINESIA |
1 |
0.0001 |
| 157 |
LABORATORY TEST ABNORMAL |
2 |
0.0001 |
| 158 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 159 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 160 |
IMMUNODEFICIENCY |
1 |
0.0001 |
| 161 |
LACRIMATION INCREASED |
2 |
0.0001 |
| 162 |
BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 163 |
OSTEOPENIA |
1 |
0.0001 |
| 164 |
DRUG ADMINISTRATION ERROR |
2 |
0.0001 |
| 165 |
PHARYNGEAL OEDEMA |
1 |
0.0001 |
| 166 |
BASAL CELL CARCINOMA |
1 |
0.0001 |
| 167 |
ARTHRITIS |
5 |
0.0001 |
| 168 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 169 |
METASTASES TO BONE |
1 |
0.0001 |
| 170 |
MULTIPLE FRACTURES |
1 |
0.0001 |
| 171 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 172 |
VIRAL INFECTION |
2 |
0.0001 |
| 173 |
CANDIDA INFECTION |
1 |
0.0001 |
| 174 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 175 |
INTENTIONAL PRODUCT USE ISSUE |
5 |
0.0001 |
| 176 |
HYPOXIA |
2 |
0.0001 |
| 177 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 178 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 179 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 180 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 181 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 182 |
DYSURIA |
2 |
0.0001 |
| 183 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 184 |
PHOTOPHOBIA |
1 |
0.0001 |
| 185 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 186 |
FOOT FRACTURE |
1 |
0.0001 |
| 187 |
LOWER LIMB FRACTURE |
1 |
0.0001 |
| 188 |
ATRIAL FIBRILLATION |
5 |
0.0001 |
| 189 |
ORAL HERPES |
1 |
0.0001 |
| 190 |
DISABILITY |
1 |
0.0001 |
| 191 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
1 |
0.0001 |
| 192 |
SINUS DISORDER |
1 |
0.0001 |
| 193 |
DISORIENTATION |
2 |
0.0001 |
| 194 |
CATARACT |
3 |
0.0001 |
| 195 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 196 |
INTENTIONAL SELF-INJURY |
1 |
0.0000 |
| 197 |
THERAPEUTIC RESPONSE DECREASED |
3 |
0.0000 |
| 198 |
STOMATITIS |
3 |
0.0000 |
| 199 |
FEEDING DISORDER |
1 |
0.0000 |
| 200 |
VERTIGO |
3 |
0.0000 |
| 201 |
ABDOMINAL DISTENSION |
5 |
0.0000 |
| 202 |
SKIN CANCER |
1 |
0.0000 |
| 203 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 204 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 205 |
APPLICATION SITE PAIN |
1 |
0.0000 |
| 206 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 207 |
TOOTH DISORDER |
1 |
0.0000 |
| 208 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 209 |
THERAPY NON-RESPONDER |
2 |
0.0000 |
| 210 |
APPLICATION SITE PRURITUS |
1 |
0.0000 |
| 211 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 212 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 213 |
HYPOKALAEMIA |
2 |
0.0000 |
| 214 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 215 |
BLOOD CHOLESTEROL INCREASED |
2 |
0.0000 |
| 216 |
ARRHYTHMIA |
2 |
0.0000 |
| 217 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 218 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 219 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
0.0000 |
| 220 |
CONTUSION |
4 |
0.0000 |
| 221 |
LOCALISED INFECTION |
1 |
0.0000 |
| 222 |
INJECTION SITE URTICARIA |
1 |
0.0000 |
| 223 |
DYSGEUSIA |
3 |
0.0000 |
| 224 |
AGEUSIA |
1 |
0.0000 |
| 225 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 226 |
HOT FLUSH |
3 |
0.0000 |
| 227 |
FLUID RETENTION |
2 |
0.0000 |
| 228 |
HYPOPHAGIA |
1 |
0.0000 |
| 229 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 230 |
SKIN ULCER |
1 |
0.0000 |
| 231 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 232 |
DEAFNESS |
1 |
0.0000 |
| 233 |
JOINT STIFFNESS |
1 |
0.0000 |
| 234 |
ANHEDONIA |
1 |
0.0000 |
| 235 |
DEPRESSED MOOD |
2 |
0.0000 |
| 236 |
GASTROOESOPHAGEAL REFLUX DISEASE |
3 |
0.0000 |
| 237 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 238 |
OEDEMA |
2 |
0.0000 |
| 239 |
LIMB INJURY |
1 |
0.0000 |
| 240 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0000 |
| 241 |
OXYGEN SATURATION DECREASED |
2 |
0.0000 |
| 242 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 243 |
PAIN IN JAW |
1 |
0.0000 |
| 244 |
RHEUMATOID ARTHRITIS |
4 |
0.0000 |
| 245 |
HYPERSOMNIA |
1 |
0.0000 |
| 246 |
HERPES ZOSTER |
2 |
0.0000 |
| 247 |
NEEDLE ISSUE |
1 |
0.0000 |
| 248 |
MUSCULOSKELETAL STIFFNESS |
3 |
0.0000 |
| 249 |
SURGERY |
2 |
0.0000 |
| 250 |
RENAL INJURY |
1 |
0.0000 |
| 251 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 252 |
HEPATIC FAILURE |
1 |
0.0000 |
| 253 |
NO ADVERSE EVENT |
6 |
0.0000 |
| 254 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 255 |
OEDEMA PERIPHERAL |
4 |
0.0000 |
| 256 |
OROPHARYNGEAL PAIN |
3 |
0.0000 |
| 257 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 258 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 259 |
NEUROPATHY PERIPHERAL |
3 |
0.0000 |
| 260 |
MIGRAINE |
3 |
0.0000 |
| 261 |
BACK PAIN |
7 |
0.0000 |
| 262 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 263 |
DIZZINESS |
15 |
0.0000 |
| 264 |
GAIT INABILITY |
1 |
0.0000 |
| 265 |
ABDOMINAL DISCOMFORT |
5 |
0.0000 |
| 266 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 267 |
ANGER |
1 |
0.0000 |
| 268 |
HEART RATE DECREASED |
1 |
0.0000 |
| 269 |
SLEEP DISORDER |
2 |
0.0000 |
| 270 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 271 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
2 |
0.0000 |
| 272 |
PRODUCT ADHESION ISSUE |
1 |
0.0000 |
| 273 |
THERAPY INTERRUPTED |
2 |
0.0000 |
| 274 |
HYPERSENSITIVITY |
5 |
0.0000 |
| 275 |
HYPOAESTHESIA |
4 |
0.0000 |
| 276 |
DYSARTHRIA |
1 |
0.0000 |
| 277 |
DRUG INEFFECTIVE |
35 |
0.0000 |
| 278 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 279 |
NAUSEA |
21 |
0.0000 |
| 280 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 281 |
BLOOD PRESSURE INCREASED |
4 |
0.0000 |
| 282 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 283 |
PAIN |
16 |
0.0000 |
| 284 |
PERIPHERAL SWELLING |
4 |
0.0000 |
| 285 |
DECREASED APPETITE |
6 |
0.0000 |
| 286 |
CHILLS |
3 |
0.0000 |
| 287 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 288 |
DRY MOUTH |
2 |
0.0000 |
| 289 |
OSTEOPOROSIS |
1 |
0.0000 |
| 290 |
ABDOMINAL PAIN UPPER |
5 |
0.0000 |
| 291 |
PRODUCT USE IN UNAPPROVED INDICATION |
6 |
0.0000 |
| 292 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 293 |
URTICARIA |
4 |
0.0000 |
| 294 |
RENAL IMPAIRMENT |
2 |
0.0000 |
| 295 |
PAIN IN EXTREMITY |
7 |
0.0000 |
| 296 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 297 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 298 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 299 |
HYPOACUSIS |
1 |
0.0000 |
| 300 |
FATIGUE |
18 |
0.0000 |
| 301 |
VAGINAL HAEMORRHAGE |
1 |
0.0000 |
| 302 |
DEVICE DISLOCATION |
1 |
0.0000 |
| 303 |
CONSTIPATION |
5 |
0.0000 |
| 304 |
INTENTIONAL PRODUCT MISUSE |
2 |
0.0000 |
| 305 |
COVID-19 |
4 |
0.0000 |
| 306 |
DEHYDRATION |
3 |
0.0000 |
| 307 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 308 |
WEIGHT INCREASED |
5 |
0.0000 |
| 309 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 310 |
VISION BLURRED |
3 |
0.0000 |
| 311 |
MEMORY IMPAIRMENT |
3 |
0.0000 |
| 312 |
SKIN IRRITATION |
1 |
0.0000 |
| 313 |
MUSCLE SPASMS |
4 |
0.0000 |
| 314 |
NASOPHARYNGITIS |
4 |
0.0000 |
| 315 |
ARTHRALGIA |
9 |
0.0000 |
| 316 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
1 |
0.0000 |
| 317 |
COUGH |
6 |
0.0000 |
| 318 |
CARDIAC DISORDER |
2 |
0.0000 |
| 319 |
PRODUCT USE ISSUE |
4 |
0.0000 |
| 320 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 321 |
DYSPHAGIA |
2 |
0.0000 |
| 322 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 323 |
ANAEMIA |
4 |
0.0000 |
| 324 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 325 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 326 |
GAIT DISTURBANCE |
4 |
0.0000 |
| 327 |
INFECTION |
3 |
0.0000 |
| 328 |
DRUG INTOLERANCE |
2 |
0.0000 |
| 329 |
PRODUCT DOSE OMISSION ISSUE |
6 |
0.0000 |
| 330 |
DRY EYE |
1 |
0.0000 |
| 331 |
SYNCOPE |
2 |
0.0000 |
| 332 |
SINUSITIS |
2 |
0.0000 |
| 333 |
ERYTHEMA |
4 |
0.0000 |
| 334 |
INFLAMMATION |
1 |
0.0000 |
| 335 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 336 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 337 |
PANCREATITIS |
1 |
0.0000 |
| 338 |
INSOMNIA |
5 |
0.0000 |
| 339 |
DIARRHOEA |
12 |
0.0000 |
| 340 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 341 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 342 |
INFLUENZA |
2 |
0.0000 |
| 343 |
PANCYTOPENIA |
1 |
0.0000 |
| 344 |
BLISTER |
1 |
0.0000 |
| 345 |
ASTHMA |
2 |
0.0000 |
| 346 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 347 |
PYREXIA |
6 |
0.0000 |
| 348 |
PALPITATIONS |
2 |
0.0000 |
| 349 |
BONE PAIN |
1 |
0.0000 |
| 350 |
NASAL CONGESTION |
1 |
0.0000 |
| 351 |
WHEEZING |
1 |
0.0000 |
| 352 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
3 |
0.0000 |
| 353 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 354 |
CONDITION AGGRAVATED |
5 |
0.0000 |
| 355 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 356 |
DISCOMFORT |
1 |
0.0000 |
| 357 |
RASH |
7 |
0.0000 |
| 358 |
INTENTIONAL OVERDOSE |
1 |
0.0000 |
| 359 |
RHINORRHOEA |
1 |
0.0000 |
| 360 |
AMNESIA |
1 |
0.0000 |
| 361 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 362 |
DEATH |
13 |
0.0000 |
| 363 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 364 |
RENAL FAILURE |
2 |
0.0000 |
| 365 |
FALL |
5 |
0.0000 |
| 366 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 367 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 368 |
BURNING SENSATION |
1 |
0.0000 |
| 369 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 370 |
HYPERTENSION |
3 |
0.0000 |
| 371 |
DYSPNOEA |
8 |
0.0000 |
| 372 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 373 |
ANXIETY |
4 |
0.0000 |
| 374 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 375 |
MOBILITY DECREASED |
1 |
0.0000 |
| 376 |
UNDERDOSE |
1 |
0.0000 |
| 377 |
ASTHENIA |
5 |
0.0000 |
| 378 |
HALLUCINATION |
1 |
0.0000 |
| 379 |
DIABETES MELLITUS |
1 |
0.0000 |
| 380 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 381 |
PARAESTHESIA |
2 |
0.0000 |
| 382 |
OFF LABEL USE |
11 |
0.0000 |
| 383 |
FEELING ABNORMAL |
3 |
0.0000 |
| 384 |
THROMBOSIS |
1 |
0.0000 |
| 385 |
TREMOR |
2 |
0.0000 |
| 386 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 387 |
BALANCE DISORDER |
1 |
0.0000 |
| 388 |
MALAISE |
5 |
0.0000 |
| 389 |
TACHYCARDIA |
1 |
0.0000 |
| 390 |
HEADACHE |
7 |
0.0000 |
| 391 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 392 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 393 |
ADVERSE EVENT |
1 |
0.0000 |
| 394 |
WEIGHT DECREASED |
3 |
0.0000 |
| 395 |
BREAST CANCER |
1 |
0.0000 |
| 396 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 397 |
DYSPEPSIA |
1 |
0.0000 |
| 398 |
HEART RATE INCREASED |
1 |
0.0000 |
| 399 |
HYPOTENSION |
2 |
0.0000 |
| 400 |
SOMNOLENCE |
2 |
0.0000 |
| 401 |
FLUSHING |
1 |
0.0000 |
| 402 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 403 |
ILLNESS |
1 |
0.0000 |
| 404 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 405 |
PNEUMONIA |
3 |
0.0000 |
| 406 |
SEPSIS |
1 |
0.0000 |
| 407 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 408 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 409 |
DEPRESSION |
2 |
0.0000 |
| 410 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 411 |
SEIZURE |
1 |
0.0000 |
| 412 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 413 |
VOMITING |
4 |
0.0000 |
| 414 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 415 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 416 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 417 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 418 |
HYPERHIDROSIS |
1 |
0.0000 |
| 419 |
PSORIASIS |
1 |
0.0000 |
| 420 |
DRY SKIN |
1 |
0.0000 |
| 421 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 422 |
HOSPITALISATION |
1 |
0.0000 |
| 423 |
DRUG INTERACTION |
1 |
0.0000 |
| 424 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 425 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 426 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 427 |
MYALGIA |
1 |
0.0000 |
| 428 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 429 |
CHEST PAIN |
1 |
0.0000 |
| 430 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 431 |
PRURITUS |
2 |
0.0000 |
| 432 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 433 |
OVERDOSE |
1 |
0.0000 |